First-in-Human Trials in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

First-in-Human Trials in Brazil

First-in-Human Trials in Brazil – Clinical Trials Services

Brazil, a country renowned for its rich cultural heritage and natural beauty, is also making significant strides in the realm of medical research and innovation. One area that has gained notable attention is the conduct of first-in-human trials. These trials mark a pivotal step in testing new medical interventions on human subjects for the first time.

In this blog, we will delve into the rising prominence of first-in-human trials in Brazil, exploring the factors fueling this trend, the advantages and challenges associated with these trials, and their potential impact on healthcare advancements in the country.

The Growing Significance of First-in-Human Trials in Brazil

Brazil’s increasing role in first-in-human trials can be attributed to several key factors. First, the country boasts a robust healthcare infrastructure, comprising world-class research institutions and renowned medical professionals. Second, Brazil’s ethnically diverse population provides a valuable resource for conducting trials, allowing for comprehensive evaluations across different genetic profiles.

Additionally, the country has implemented a regulatory framework that facilitates the conduct of clinical trials, attracting both domestic and international pharmaceutical companies to choose Brazil as a preferred destination for first-in-human trials.

Benefits of First-in-Human Trials

First-in-human trials offer significant benefits that contribute to medical progress. These trials enable researchers to evaluate the safety, dosage, and potential efficacy of new interventions in human subjects, thereby accelerating the translation of scientific discoveries into practical treatments.

By hosting such trials, Brazil provides patients with early access to groundbreaking therapies that may not be available elsewhere. Furthermore, these trials foster collaboration between local and international researchers, promoting knowledge exchange and elevating Brazil’s standing in the global research community.

Challenges and Ethical Considerations

While first-in-human trials hold immense promise, they also pose unique challenges and ethical considerations. Participant safety is of paramount importance, and stringent protocols must be followed to mitigate risks. Informed consent and transparent communication throughout the trial process are critical ethical considerations.

Moreover, robust monitoring and regulatory mechanisms are necessary to prevent any potential exploitation. Brazil has made significant strides in addressing these challenges, aligning its regulations with international standards and working closely with ethical review boards to ensure participant welfare and rights.

First-in-Human Trials in Brazil

First-in-Human Trials in Brazil

First-in-Human Trials in Brazil

Impact on Healthcare Advancements

Brazil’s active participation in first-in-human trials positions the country as a catalyst for healthcare advancements. Collaborations with pharmaceutical companies and research institutions attract cutting-edge research projects and clinical trials, fostering innovation, investment, and growth in the local healthcare industry.

Furthermore, the knowledge gained from these trials informs healthcare policies, facilitates the development of personalized medicine, and enhances treatment outcomes for patients across the country. Brazil’s involvement in first-in-human trials contributes to the global pursuit of improved patient care.

Current Initiatives and Success Stories

Brazil has witnessed notable success stories in first-in-human trials across various medical disciplines. These trials have focused on groundbreaking cancer therapies, innovative medical devices, and revolutionary gene therapies. The positive outcomes and significant contributions to medical science have not only granted patients access to life-changing treatments but have also attracted attention from global pharmaceutical companies and researchers.

These success stories solidify Brazil’s position as an attractive destination for first-in-human trials and open doors for exciting collaborations and future breakthroughs.

Collaborations and Knowledge Exchange

Brazil actively fosters collaborations between local and international researchers, facilitating knowledge exchange and driving innovation. These collaborations enable the sharing of expertise, resources, and technologies, resulting in accelerated advancements in medical research.

International collaborations provide Brazilian researchers with exposure to diverse perspectives and approaches, enhancing their skills and expanding their professional networks. Such interactions contribute to the growth and reputation of Brazil’s healthcare and research sectors, positioning the country as a key player in the global medical research landscape.


Brazil’s increasing involvement in first-in-human trials reflects its commitment to advancing medical research and innovation. With its robust healthcare infrastructure, diverse population, and supportive regulatory framework, Brazil is emerging as an attractive destination for conducting these transformative trials.

By embracing the opportunities presented by first-in-human trials, Brazil has the potential to drive healthcare advancements, enhance patient access to cutting-edge treatments, and make significant contributions to the global pursuit of improved healthcare outcomes. The future of medical research in Brazil looks promising, with first-in-human trials at the forefront of medical breakthroughs.


First-in-Human Trials in Brazil

Source: Duke Clinical Research Institute

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

First-in-Human Trials in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
First-in-Human Trials in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

First-in-Human Trials in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

First-in-Human Trials in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

First-in-Human Trials in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

First-in-Human Trials in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
First-in-Human Trials in Brazil

The Cohortias Team

First-in-Human Trials in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

First-in-Human Trials in Brazil

Network & Partnerships